Sun Pharma has announced that the company has presented Sun Pharma Presents ODOMZO® and LEVULAN® KERASTICK® + BLU-U® Data to treat patients suffering from Skin Cancer. The company has presented these data analysis at the Virtual Meeting of the American Academy of Dermatology (AAD). These virtual meetings are to be scheduled on June 12-14, 2020.
Skin Cancer is widely regarded as the most common type of cancer and it is commonly known as the nonmelanoma Skin cancers. It is expected that the Skin Cancer affected more than 4 million US citizens each year, a rate that has doubled in the last 5 decades. This cancer is 100% curable, only treated properly.
Senior Medical Director of Sun Pharma. Nicholas Squittieri, M.D., said “With incidence rates increasing and more treatment options needed, we are committed to providing clinical support for our medicines and helping address the needs of patients who are impacted by the different stages of skin cancer.”
“The evidence presented at the AAD Virtual Meeting Experience offers important insights and guidance to dermatology healthcare providers who are using ODOMZO and LEVULAN in their daily clinical practice,” Nicholas Squittieri further added.
Vice-Chairman of the Department of Dermatology, University Hospital of Zurich, Switzerland, Prof. Reinhard Dummer, M.D., said, “Our research showed that the positive efficacy and safety benefits of ODOMZO were not impacted by commonly used medicines like statins or nonsteroidal anti-inflammatory drugs that some patients may need to take simultaneously to treat other health conditions.”
“Since basal cell carcinoma is more commonly found in older adults, these insights are reassuring for dermatologists who are considering ODOMZO for their older patients,” Vice-Chairman of the Department of Dermatology, University Hospital of Zurich, Switzerland, Prof. Reinhard Dummer further added.
Jordan Eaton holds a postgraduate degree in Software Engineering from Canada. ‘The stock market is filled with individuals who know the price of everything, but the value of nothing.’ Jordan is a share market expert, being personally invested for over 4 years. He believes the most valuable nugget of wisdom for new investors is a quote from Phillip Fisher. He has been writing his entire life, and while he has made a career of business and finance reporting, he still enjoys writing short stories and poetry.
Jordan has worked as financial analyst until his retirement. He is a well-known research director and portfolio manager for more than 5 years. After many years in the market, he dedicated all his time to write articles highlighting Business category.
Address: 2879 South Louisiana Avenue, Roswell, NM 88203 USA
Email: [email protected]